Bayer Vietnam announces strategic partnership with National Obstetrics Hospital

The partnership aims to improve the knowledge and clinical experience of ob-gyn healthcare professionals while enhancing public awareness of gynecological health issues and empowering women to take control of their health and well-being.

This collaboration will also utilize the partners’ complementary strengths and capabilities to improve knowledge and clinical expertise among obstetricians and gynecologists, while enhancing public awareness of women’s health issues and promoting self-care through educational online and offline platforms.

The MoU spans from 2023 to 2025 to allow time for major initiatives to be launched and achieve results.

Bayer Vietnam and National Obstetrics Hospital sign strategic partnership. Photo by Nhat Minh

For healthcare professionals, Bayer Vietnam and the National Hospital of Obstetrics and Gynecology (NHOG) will coordinate to develop and deliver training content. They will also continue medical education programs and scientific seminars focused on the correct and safe use of modern contraceptive methods.

The latest treatments and therapies will focus on gynecological conditions like endometriosis, heavy menstrual bleeding, vaginal infections and menopause management, with up-to-date guidelines on pregnancy nutrition, and self-care solutions.

The partnership will also include collaboration with international ob-gyn organizations and experts to exchange the latest knowledge and information, ensuring the local medical community stays abreast of global developments and innovations to deliver higher-quality healthcare for Vietnamese women.

For the general public, disease awareness campaigns will be implemented across multiple channels, both online and offline, to educate women about reproductive health and gynecological problems, and encourage them to seek preventative care and early treatment, which will lead to improved quality of life and reduced risk of future health issues.

By leveraging the power of digital platforms and social media channels, the initiative will combine the hospital's expertise and patient insights with the company's resources and capabilities. The impact of these efforts can be multiplied, increasing the reach and credibility of the campaign message, and contributing to the sustainable development of the healthcare industry.

Associate Prof. Tran Danh Cuong MD Ph.D., Director of the National Hospital of Obstetrics and Gynecology, said: "Educating both physicians and patients is essential for transforming healthcare quality, benefiting both patients and the medical community. Working together with Bayer Vietnam allows us to optimize our expertise in women’s health and broaden our outreach to improve public health literacy as well as the professional capacity of the healthcare workforce, not only at our hospital but also in satellite hospitals across the country. We hope this will open up the prospect of identifying new effective diagnoses and treatment options in the field of ob-gyn, and elevate the standard of care for women in Vietnam."

Associate Prof. Tran Danh Cuong MD Ph.D., Director of the National Hospital of Obstetrics and Gynecology. Photo by Nhat Minh

Ingo Brandenburg, Managing Director of Bayer Vietnam, emphasized: "At Bayer, care is the core of our work, and women’s healthcare is in our DNA. We are thrilled to partner with Vietnam’s National Hospital of Obstetrics and Gynecology, which shares our mission of advancing care and addressing unmet needs in women's health. I very much look forward to seeing the fruits of our collaboration, a future where each and every woman has access to quality healthcare services and is empowered to reach her full potential in life."

This MoU aligns with the company’s strategy of fostering collaborative relationships across the healthcare industry with a patient-and-consumer-centric approach to realize its vision of "Health for all, Hunger for none."

Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population.

In fiscal 2022, the group employed around 101,000 people and posted sales of 50.7 billion euros. R&D expenses before special items amounted to 6.2 billion euros.

For more information, go to www.bayer.com.